Integral Diagnostics (ASX:IDX) buys X-Ray Group

Company News

by Melissa Darmawan

Medical imaging services Integral Diagnostics (ASX:IDX) has put in a offer to acquire the X-Ray Group for up to $37.5 million.

Integral Diagnostics provides imaging services to 67 radiology clinics across Australia and New Zealand.

Under the deal, $25.95 million will be paid in cash while $11.55 million will be issued as shares that will be under an escrow arrangement, that means the shares are unable to be sold and/or transferred until year four of the issue.

There could also be another $6.5 million on the table, conditional on EBITDA performance metrics between financial years 2022 and 2023.

The X-Ray Group has forecasted EBITDA between $5 million to $5.5 million in FY 2022 before any Covid-19 costs.

The transaction is slated to be complete in November this year, subject to “customary conditions”.

Shares in Integral Diagnostics (ASX:IDX) are trading 3.8 per cent higher at $4.91.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.